Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
A very different experience to the loading doses
The Food and Drug Administration (FDA) has not approved Ozempic for weight management, but it has been shown to help manage body weight
[DOI] [PubMed] [Google Scholar] 715.Burmeister M.A., Brown J.D., Ayala J.E., Stoffers D.A., Sandoval D.A., Seeley R.J
Otherwise, it may not work properly or could even put one's health in danger